tert-Butyl 1-oxa-8-azaspiro[4.5]decane-8-carboxylate, 95.0%, 5g

2,5-DIPHENYL-1,4-BENZOQUINONE, 95.0%, 1g

4-Methoxyphenylacetone, 98.0%, 1g

Methylamine Hydrobromide (Low water content)>98.0%(N)(T)1g

(S)-tert-Butyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride, 98%, 25g

(R)-1-Cbz-beta-Prolinol, 95.0%, 5g

N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE, 95%, 1mg

2-(4-fluorophenyl)imidazo[1,2-{a}]pyridin-3-amine, 95.0%, 500mg

5-Methyl-1-phenylpyridin-2(1H)-one, 95.0%, 25g

Columna HPLC NUCLEODUR® C8 Gravedad 5 µm, 250 mm, 4,6 mm, 1 Pieza(s)

Carbamic acid, [2-(4-chlorophenyl)ethyl]-, 1,1-dimethylethyl ester (9CI), 97%, 100mg

2,6-Dimethylbenzaldehyde>97.0%(GC)5g

3,6-Dibromophthalic Anhydride>98.0%(T)1g